Irritable Bowel Research-2016 Jul

Irritable Bowel Research-2016 Jul

in 2016, Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes BACKGROUND: The commonality in symptomatology in these conditions displaying hyperalgesia and central sensitization with possible common underlying pathophysiology suggests that a clinical endocannabinoid deficiency might characterize their origin. You can read the full article here .. Read More

Headache Review -2017

In 2017, Mini Review of The Use of Cannabis for Headache Disorders BACKGROUND: This review considers historical prescription practices, summarizes the existing reports on the use of cannabis for headache, and examines the preclinical literature exploring the role of exogenous and endogenous cannabinoids to alter headache pathophysiology. You can read the full article here => http://online.liebertpub.com/doi/pdfplus/10.1089/can.2016.0033

Fibromyalgia Research-2016 Jul

in 2016, Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes BACKGROUND: The commonality in symptomatology in these conditions displaying hyperalgesia and central sensitization with possible common underlying pathophysiology suggests that a clinical endocannabinoid deficiency might characterize their origin. You can read the full article here .. Read More

Dravet Syndrome Research-2017 May

in 2017, Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome  BACKGROUND: In this double-blind, placebo-controlled trial, we randomly assigned 120 children and young adults with the Dravet syndrome and drug-resistant seizures to receive either cannabidiol oral solution at a dose of 20 mg per kilogram of body weight per day or placebo, in .. Read More

Pediatric Epilepsy Research-2015 Jun

In 2015, Cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome. With 117 parents. BACKGROUND: We sought to document the experiences of children with IS and/or LGS who have been treated with CBD-enriched cannabis preparations. We conducted a brief online survey of parents who administered CBD-enriched cannabis .. Read More

Pediatric Epilepsy Research-2017 May

In 2017, Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome BACKGROUND. Multinational, randomized, double-blind trial of adjunctive cannabidiol versus placebo in children and young adults 2 to 18 years of age with the Dravet syndrome whose seizures were not controlled by their current antiepileptic-drug regimen. The trial comprised a 4-week baseline period, a 14-week .. Read More

Dravet Syndrome Study-2013 Dec

In 2013, Parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy BACKGROUND: Thirteen children had Dravet syndrome, four had Doose syndrome, and one each had Lennox-Gastaut syndrome and idiopathic epilepsy. The average number of anti-epileptic drugs (AEDs) tried before using cannabidiol-enriched cannabis was 12. You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/

Dravet Syndrome Research-2015 Jun

In 2015, Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy BACKGROUND: Sought to document the experiences of children with IS and/or LGS who have been treated with CBD-enriched cannabis preparations. We conducted a brief online survey of parents who administered CBD-enriched cannabis preparations for the treatment of their children’s epilepsy. We specifically recruited .. Read More

Type 2 Diabetes Research-2015 Jul

In 2015, Cannabis Smoking and Diabetes Mellitus: BACKGROUND: We offer epidemiological estimates from eight independent replications from (1) the National Health and Nutrition Examination Surveys, and (2) the National Surveys on Drug Use and Health (2005-12). You can read the full article here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801109/